Partner News

Sarepta News Banner

Sarepta Announces Results From SRP-9001 Study

Sarepta today announced topline results from Part 2 of Study 102, an ongoing, randomized, double-blind, placebo-controlled clinical trial evaluating its investigational gene transfer therapy SRP-9001 in Duchenne patients.   In […]

Pfizer News Banner

Pfizer Letter to the Duchenne Community

Update on Pfizer’s Duchenne gene therapy Phase 3 clinical program In line with our continued efforts to work with the Duchenne community and share information as it becomes available, we […]